Cell and gene therapies and viral vaccines need higher yields. That's our specialty. We substantially increase yields by addressing the innate antiviral defenses within production cells. These defenses, designed to resist foreign genetic material and viral replication, work against your process. We have developed a unique panel of small molecules (VIRAL SENSITIZERS) that turn off these antiviral responses in cells. We first identified our novel viral sensitizers by employing an innovative high-throughput screening process. Virica continues to employ this cutting-edge equipment and can identify the most synergistic viral sensitizer molecules from our library for any virus or cell line. We can tailor formulations of our viral sensitizers to boost virus yield in your manufacturing facility or improve the effects of your viral therapies.
Something looks off?